Omeros Corp at UBS Global Healthcare Conference Transcript
Good morning, everyone, and welcome to the 2019 UBS Global Healthcare Conference. My name is Mallet Njonkem, and I'm pleased to be your host this session. Please join me in welcoming our first presenter Dr. Greg Demopulos, Chairman and CEO of Omeros Corporation. There'll be a breakout session immediately following in the Uris room.
Thank you, and enjoy.
Hi. Good morning, everyone. We appreciate you joining us. I'd like to thank UBS for hosting us today. As a reminder, some of the statements will be forward looking, and I refer you to our most recent 10-Q.
Sales for OMIDRIA, our marketed ophthalmic drug continue to grow, and our pipeline behind OMIDRIA continues to make significant progress. I'll provide updates on a number of these programs today as time allows. The presentation contains a lot of information, but this will be posted on our website.
Omeros now stands at about 240 employees with dozens of additional positions that we
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |